Gilead Sciences Inc.’s COVID-19 drug remdesivir will cost much less than Wall Street analysts had predicted in a move that likely points to a more measured and responsible approach to the price of treatments and vaccines during the pandemic. Gilead GILD Shares, It gained 0.9% in trading on Monday following …
Read More »
Shares of Inovio Pharmaceuticals Inc. rebounded to a 20-year high in high volumes on Friday, erasing a previous sharp loss, after a longtime bull downgraded the Pennsylvania-based biotech company, and later that the company disclosed some terms of the funding agreement with the US Department of Defense announced earlier this …
Read More »
The White House coronavirus task force is slated to hold its first news briefing in nearly two months on Friday as new coronavirus cases continue to emerge in much of the country. Vice President Mike Pence will lead the briefing, according to the Department of Health and Human Services, but …
Read More »
The United States reported more than 34,400 coronavirus cases on Wednesday, according to a CNBC analysis of data from Johns Hopkins University, after health officials in California, Florida and Texas reported record single-day spikes. As of Wednesday, the seven-day average of new Covid-19 cases in the country was 31,172. This …
Read More »
Vaccine makers were climbing during Thursday’s volatile market session when investors took President Trump’s bullish proclamation on Wednesday that a vaccine to treat COVID-19 is closer than many expected to hear. Inovio Pharmaceuticals (INO) – Get report jumped more than 17% on Thursday, while Sorrento (SRNE) – Get report Almost …
Read More »